A wound model for decubitus and leg ulcers consisting of human dermal fibroblasts in type I collagen dermal "equivalent" matrix (DEM) was exposed in vitro to electric fields similar to postulated endogenous fields in wounds. After an 8-10 day maturation period, conductivity of DEM samples was determ
Conductivity of a chronic wound model
β Scribed by Robert Goldman; Solomon Pollack
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 482 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0197-8462
No coin nor oath required. For personal study only.
β¦ Synopsis
The dermal equivalent matrix (DEM) is well recognized as an in vitro model of wound healing. To quantify the low-frequency (10-100 Hz) electric fields that cause proliferative effects in this model, determination of conductivity is a prerequisite. This article outlines a four-electrode technique to establish conductivity of DEM at 100 Hz. DEM is fabricated from human foreskin fibroblasts and collagen type I extracted from rat tail. Over 8-10 days, fibroblasts contract translucent collagen matrices into opaque circular "dime-sized'' structures that are approximately 10 mm in diameter and 1 mm thick. To determine conductivity, rectangular samples are cut from each matrix. Thickness and width of each sample is measured by microscopy. Over 17 experiments, conductivity of multiple samples is found to be related inversely to cell density in matrix, with 1.22 Siemendmeter (Slm) corresponding to 0 cells/mm' matrix and 0.78 Slm corresponding to 2.6X lo4 cells/mm'. These results are consistent with a physical model of DEM consisting of pores within a framework of type 1 collagen; the cells and medium are within the pores. The model is most compatible with a relative pore area of 73% and a cell volume of 9.0 X mm3 (the latter in agreement with published fibroblast dimensions). From these results, DEM is much more porous than dermis. Although DEM has been recognized as a reasonable model of chronic wound healing, this dissimilarity is noted.
π SIMILAR VOLUMES
## Abstract Nonhealing wounds remain a major health problem whose treatment is challenging and costly. Treatments based on cells or growth factors are still not very effective. We developed an entirely novel strategy consisting in treatment of the woundβtissue matrix with biopolymers engineered to